Chester County News and Community Website
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced its participation in two scheduled healthcare conferences in March 2025, where the company’s leadership team will provide insights into its …
Aclaris Therapeutics to Participate in Upcoming Healthcare Conferences Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced the issuance of inducement awards in the form of Restricted Stock Units (RSUs) to three recently hired non-executive employees. These awards, …
Neuronetics Grants Inducement Awards to New Employees Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced that the European Commission has granted Advanced Therapy Medicinal Product (ATMP) classifications for its gene therapies OCU410 and OCU410ST. This regulatory milestone …
Ocugen Secures ATMP Classification for Gene Therapies Targeting Vision Loss Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced plans to host a conference call and live webcast on Tuesday, March 11, 2025, at 4:30 p.m. ET. The …
Verrica Pharmaceuticals Announces Q4 & Full Year 2024 Financial Results Webcast Read More
BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has commended Nanomerics for the successful completion of a human study utilizing its proprietary Molecular Envelope Technology (MET). The Phase I SUNLIGHT trial …
Virpax Pharmaceuticals Applauds Successful Trial of Molecular Envelope Technology Read More
EXTON, PA — Bentley Systems, Incorporated (Nasdaq: BSY) announced its financial performance for the fourth quarter and full year of 2024, reporting solid growth in subscription revenues and annual recurring revenues …
Bentley Systems Reports Strong 2024 Financial Results and Sets Optimistic 2025 Outlook Read More
NEWTOWN, PA — Traws Pharma, Inc. (Nasdaq: TRAW) has announced its successful return to compliance with Nasdaq’s minimum stockholders’ equity requirements, ensuring the continuation of its listing on the Nasdaq Capital …
Traws Pharma Regains Nasdaq Compliance, Strengthening Position for 2025 Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has announced plans to release its fourth quarter and full-year 2024 financial results on Thursday, March 20, 2025. The company’s management will host …
TELA Bio to Announce Fourth Quarter and Full-Year 2024 Financial Results Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced a significant milestone with the U.S. Food and Drug Administration (FDA), gaining alignment to advance its Phase 2/3 pivotal confirmatory trial of OCU410ST, …
FDA Greenlights Ocugen’s Breakthrough Gene Therapy Trial, Offering New Hope for Stargardt Disease Patients Read More WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced its fourth quarter and full-year 2024 financial results, along with key pipeline advancements and corporate updates signaling a pivotal year ahead.
Aclaris Reports 2024 Financial Results and Sets Stage for Transformative 2025 Read More